Radiofrequency Ablation Devices Market by Application (Cardiology, Oncology, and Pain Management), Product Type (Devices and Disposables) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key benefits

1.3 Key market segments

1.4 Research methodology

1.4.1 Secondary research

1.4.2 Primary research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

2.2 Market beyond: what to expect by 2027 ($million)

2.2.1 Moderate Growth Scenario

2.2.2 Rapid growth scenario

2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top investment pockets

3.2.2 Top winning strategies

3.3 Government regulations

3.3.1 U.S. FDA

3.3.2 Europe CE Mark

3.3.3 Ministry of Health, Labour and Welfare (MHLW)

3.4 Reimbursement scenarios

3.5 Porter's five forces analysis

3.5.1 Low bargaining power of suppliers

3.5.2 Moderate bargaining power of buyers

3.5.3 Low threat of new entrants

3.5.4 Low threat of substitutes

3.5.5 Moderate competitive rivalry

3.6 Clinical trials

3.7 Patent analysis

3.7.1 China: Patent Analysis by Market Participants

3.7.2 The U.S.: Patent Analysis by Market Participants

3.7.3 Europe: patent analysis, by market participant

3.7.4 Canada: patent analysis, by market participant

3.7.5 Others: Patent Analysis, by Market Participant

3.8 Top player positioning, 2015

3.9 Top impacting factors

3.9.1 Drivers

3.9.1.1 Rise in the prevalence of cancer and cardiac diseases

3.9.1.2 Increase in the number of patients suffering from pain

3.9.1.3 High efficacy and short duration of the procedure

3.9.2 Restrains

3.9.2.1 High cost of treatment

3.9.2.2 Limited awareness

3.9.2.3 Availability of other treatments

3.9.3 Opportunities

3.9.3.1 Lucrative opportunities in emerging markets

3.9.3.2 Untapped RFA market opportunity

3.9.3.3 Recent advancements

CHAPTER 4 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION

4.1 Overview

4.1.1 Market size and forecast

4.2 Cardiology

4.2.1 Key market trends

4.2.2 Key growth factors and opportunities

4.2.3 Market size and forecast

4.2.4 Irrigated-tip RF ablation catheters

4.2.5 Conventional RF ablation catheters

4.3 Oncology

4.3.1 Key market trends

4.3.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.3.4 Breast cancer

4.3.5 Colorectal cancer

4.3.6 Lung cancer

4.3.7 Prostate cancer

4.3.8 Liver cancer

4.3.9 Kidney cancer

4.3.10 Spinal metastases

4.3.11 Other cancers

4.4 Pain management

4.4.1 Key market trends

4.4.2 Key growth factors and opportunities

4.4.3 Market size and forecast

4.4.4 Neck pain

4.4.5 Shoulder pain

4.4.6 Upper back pain

4.4.7 Lower back pain

4.4.8 Knee pain

4.4.9 Other pain syndromes

CHAPTER 5 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE

5.1 Overview

5.1.1 Market size and forecast

5.2 Devices

5.2.1 Key market trends

5.2.2 Key growth factors and opportunities

5.2.3 Market size and forecast

5.3 Disposables

5.3.1 Key market trends

5.3.2 Key growth factors and opportunities

5.3.3 Market size and forecast

CHAPTER 6 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends

6.2.2 Key growth factors and opportunities

6.2.3 Market size and forecast

6.2.4 U.S. market size & forecast

6.2.5 Canada market size & forecast

6.2.6 Mexico market size & forecast

6.3 Europe

6.3.1 Key market trends

6.3.2 Key growth factors and opportunities

6.3.3 Market size and forecast

6.3.4 Germany market size & forecast

6.3.5 France market size & forecast

6.3.6 U.K. market size & forecast

6.3.7 Italy market size & forecast

6.3.8 Spain market size & forecast

6.3.9 Russia market size & forecast

6.3.10 Rest of Europe market size & forecast

6.4 Asia-Pacific

6.4.1 Key market trends

6.4.2 Key growth factors and opportunities

6.4.3 Market size and forecast

6.4.4 Japan market size & forecast

6.4.5 China market size & forecast

6.4.6 Australia market size & forecast

6.4.7 India market size & forecast

6.4.8 South Korea market size & forecast

6.4.9 Taiwan market size & forecast

6.4.10 Rest of Asia Pacific market size & forecast

6.5 Latin America, Middle East, Africa (LAMEA)

6.5.1 Key market trends

6.5.2 Key growth factors and opportunities

6.5.3 Market size and forecast

6.5.4 Brazil market size & forecast

6.5.5 Turkey market size & forecast

6.5.6 Venezuela market size & forecast

6.5.7 Saudi Arabia market size & forecast

6.5.8 Republic of South Africa market size & forecast

6.5.9 Rest of LAMEA market size & forecast

CHAPTER 7 COMPANY PROFILES

7.1 Halyard Health, Inc.

7.1.1 Company overview

7.1.2 Operating business segments

7.1.3 Business performance

7.2 Stryker Corporation

7.2.1 Company overview

7.2.2 Operating business segments

7.2.3 Business performance

7.2.4 Key strategic moves & developments

7.3 St. Jude Medical, Inc.

7.3.1 Company overview

7.3.2 Operating business segments

7.3.3 Business performance

7.3.4 Key strategic moves & developments

7.4 Medtronic PLC

7.4.1 Company overview

7.4.2 Operating business segments

7.4.3 Business performance

7.4.4 Key strategic moves & developments

7.5 Boston Scientific Corporation

7.5.1 Company overview

7.5.2 Operating business segments

7.5.3 Business performance

7.5.4 Key strategic moves & developments

7.6 C. R. Bard, Inc.

7.6.1 Company overview

7.6.2 Operating business segments

7.6.3 Business performance

7.6.4 Key strategic moves & developments

7.7 AngioDynamics, Inc.

7.7.1 Company overview

7.7.2 Operating business segments

7.7.3 Business performance

7.7.4 Key strategic moves & developments

7.8 Hologic, Inc.

7.8.1 Company overview

7.8.2 Operating business segments

7.8.3 Business performance

7.8.4 Key strategic moves & developments

7.9 AtriCure, Inc.

7.9.1 Company overview

7.9.2 Operating business segments

7.9.3 Business performance

7.9.4 Key strategic moves & developments

7.10 Johnson and Johnson

7.10.1 Company overview

7.10.2 Operating business segments

7.10.3 Business performance

7.10.4 Key Strategic moves & developments

*Other players in the value chain include

• Baylis Medical
• Arthrex, Inc.
• inomed Medizintechnik GmbH
• Sutter Medizintechnik GmbH
• Bramsys Indstria e Comrcio Ltda
• ENDO-FLEX GmbH
• Epimed International
• sfm medical devices GmbH

*Profiles of these players are not included. The same will be included on request.

List of Figures

FIG. 1 TOP INVESTMENT POCKETS: WORLD RADIOFREQUECNY ABLATION DEVICES MARKET, BY APPLICATION

FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)

FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE

FIG. 4 PORTERS FIVE FORCES ANALYSIS

FIG. 5 PATENTS REGISTERED/APPROVED WORLDWIDE, 20132016

FIG. 6 CHINA: PATENT ANALYSIS BY MARKET PARTICIPANTS, 20132016

FIG. 7 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

FIG. 8 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

FIG. 9 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2013 THROUGH 2016

FIG. 10 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

FIG. 11 TOP PLAYER POSITIONING, 2015

FIG. 12 TOP IMPACTING FACTORS

FIG. 13 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 2015

FIG. 14 IRRIGATED-TIP RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)

FIG. 15 CONVENTIONAL RF ABLATION CATHETERS MARKET, 20142022 ($MILLION)

FIG. 16 BREAST CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 17 COLORECTAL CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 18 LUNG CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 19 PROSTATE CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 20 LIVER CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 21 KIDNEY CANCER RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 22 SPINAL METASTASES RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 23 OTHER CANCERS RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 24 NECK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 25 SHOULDER PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 26 UPPER BACK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 27 LOWER BACK PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 28 KNEE PAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 29 OTHER PAIN SYNDROMES RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 30 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE, 2015

FIG. 31 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY GEOGRAPHY, 2015

FIG. 32 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015

FIG. 33 U.S. RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 34 CANADA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 35 MEXICO RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 36 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015

FIG. 37 GERMANY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 38 FRANCE RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 39 U.K. RADIOFREQUENCY ABLATION DEVICES MARKET, 2015

FIG. 40 ITALY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 41 SPAIN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 42 RUSSIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 43 REST OF EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 44 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015

FIG. 45 JAPAN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 46 CHINA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 47 AUSTRALIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 48 INDIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 49 SOUTH KOREA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 50 TAIWAN RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 51 REST OF ASIA PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 52 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 2015

FIG. 53 BRAZIL RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 54 TURKEY RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 55 VENEZUELA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 56 SAUDI ARABIA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 57 REPUBLIC OF SOUTH AFRICA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 58 REST OF LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, 20142022 ($MILLION)

FIG. 59 HALYARD: REVENUE, BY YEAR ($MILLION)

FIG. 60 HALYARD: REVENUE, BY SEGMENT, 2015 (%)

FIG. 61 HALYARD: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 62 STRYKER: REVENUE, BY YEAR ($MILLION)

FIG. 63 STRYKER: REVENUE, BY SEGMENT, 2015 (%)

FIG. 64 STRYKER: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 65 ST. JUDE MEDICAL: REVENUE, BY YEAR ($MILLION)

FIG. 66 ST. JUDE MEDICAL: REVENUE, BY PRODUCT, 2015 (%)

FIG. 67 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 68 MEDTRONIC: REVENUE, BY YEAR ($MILLION)

FIG. 69 MEDTRONIC: REVENUE, BY SEGMENT, 2016 (%)

FIG. 70 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2016 (%)

FIG. 71 BOSTON: REVENUE, BY YEAR ($MILLION)

FIG. 72 BOSTON: REVENUE, BY SEGMENT, 2015 (%)

FIG. 73 BOSTON: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 74 BARD: REVENUE, BY YEAR ($MILLION)

FIG. 75 BARD: REVENUE, BY SEGMENT, 2015 (%)

FIG. 76 BARD: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 77 ANGIODYNAMICS: REVENUE, BY YEAR ($MILLION)

FIG. 78 ANGIODYNAMICS: REVENUE, BY SEGMENT, 2016 (%)

FIG. 79 ANGIODYNAMICS: REVENUE, BY GEOGRAPHY, 2016 (%)

FIG. 80 HOLOGIC: REVENUE, BY YEAR ($MILLION)

FIG. 81 HOLOGIC: REVENUE, BY GEOGRAPHY (%)

FIG. 82 HOLOGIC: REVENUE, BY PRODUCT (%)

FIG. 83 ATRICURE: REVENUE, BY YEAR ($MILLION)

FIG. 84 ATRICURE: REVENUE, BY PRODUCT, 2015 (%)

FIG. 85 ATRICURE: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 86 J&J: REVENUE, BY YEAR ($MILLION)

FIG. 87 J&J: REVENUE, BY SEGMENT, 2015 (%)

FIG. 88 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 RADIOFREQUENCY ABLATION DEVICES MARKET, MODERATE GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 2 RADIOFREQUENCY ABLATION DEVICES MARKET, RAPID GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 3 RADIOFREQUENCY ABLATION DEVICES MARKET, DIMINISHING GROWTH SCENARIO, BY GEOGRAPHY, 20222027 ($MILLION)

TABLE 4 CLINICAL TRIALS, RADIOFREQUENCY ABLATION DEVICES MARKET, 20132016

TABLE 5 PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE, AND JAPAN (20132016)

TABLE 6 CHINA: PATENT ANALYSIS BY MARKET PARTICIPANTS, 20132016

TABLE 7 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

TABLE 8 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

TABLE 9 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

TABLE 10 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 20132016

TABLE 11 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)

TABLE 12 WORLD CARDIOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)

TABLE 13 WORLD CARDIOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)

TABLE 14 WORLD ONCOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)

TABLE 15 WORLD ONCLOLOGY RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)

TABLE 16 WORLD PAIN MANAGEMENT RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)

TABLE 17 WORLD PAIN MANAGEMENT RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)

TABLE 18 KEY SPECIFICATIONS OF DISPOSABLES USED DURING RADIOFREQUENCY ABLATION PROCEDURE

TABLE 19 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY PRODUCT TYPE, 20142022 ($MILLION)

TABLE 20 WORLD RADIOFREQUENCY ABLATION MARKET FOR DEVICES, BY REGION, 20142022 ($MILLION)

TABLE 21 WORLD RADIOFREQUENCY ABLATION MARKET FOR DISPOSABLES, BY REGION, 20142022 ($MILLION)

TABLE 22 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)

TABLE 23 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)

TABLE 24 NORTH AMERICA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 25 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)

TABLE 26 EUROPE RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 27 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)

TABLE 28 ASIA-PACIFIC RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 29 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)

TABLE 30 LAMEA RADIOFREQUENCY ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 31 HALYARD - COMPANY SNAPSHOT

TABLE 32 HALYARD - OPERATING SEGMENTS

TABLE 33 STRYKER - COMPANY SNAPSHOT

TABLE 34 STRYKER - OPERATING SEGMENTS

TABLE 35 ST. JUDE MEDICAL - COMPANY SNAPSHOT

TABLE 36 ST. JUDE MEDICAL - OPERATING SEGMENTS

TABLE 37 MEDTRONIC - COMPANY SNAPSHOT

TABLE 38 MEDTRONIC OPERATING SEGMENTS

TABLE 39 BOSTON - COMPANY SNAPSHOT

TABLE 40 BOSTON OPERATING SEGMENTS

TABLE 41 BARD COMPANY SNAPSHOT

TABLE 42 BARD - OPERATING SEGMENTS

TABLE 43 ANGIODYNAMICS - COMPANY SNAPSHOT

TABLE 44 ANGIODYNAMICS - OPERATING SEGMENTS

TABLE 45 HOLOGIC - COMPANY SNAPSHOT

TABLE 46 HOLOGIC - OPERATING SEGMENTS

TABLE 47 ATRICURE - COMPANY SNAPSHOT

TABLE 48 ATRICURE - OPERATING SEGMENTS

TABLE 49 J&J - COMPANY SNAPSHOT

TABLE 50 J&J - OPERATING SEGMENTS